The effects and costs of a multidisciplinary symptomatic treatment strategy on quality of life of people severely affected by MS

The effects and costs of a multidisciplinary symptomatic treatment strategy on quality of life of people severely affected by MS - MS-Care NU

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44570

Enrollment

Registered

2017-12-12

Start date

2018-01-03

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: a referral to Nieuw Unicum and a diagnosis Multiple Sclerosis

Exclusion criteria

Exclusion criteria: Individuals who are mentally incompetent to give informed consent will not be included in the study.

Design outcomes

Primary

Measure	Time frame
The change in quality of life, caregivers burden and functional domains from baseline to endpoint will be evaluated. The primary outcome parameters are the Euroqol (EQ-5d-5l) and the Adult Social Care Outcome Toolkit (ASCOT) for respectively health-related- and social related quality of life.	—

Secondary

Measure	Time frame
1. Disability (meetinstrumenten: Functional independent measure en Multiple Sclerosis Impact Profile) 2. Caregiver strenght (Caregiver Strain Index) 3. Costs (Medical Consumption Questionnaire)	—

Countries

Netherlands

Outcome results